Cargando…
Comprehensive Analysis of the Implication of PGRMC1 in Triple-Negative Breast Cancer
TNBC represents the most malignant subtype of breast cancer with heterogenicity and poor prognosis. PGRMC1 has been reported to predict worse prognosis and correlate with MHT mediated signal transduction in breast cancer, whereas its involvement in TNBC remains poorly explored. The purpose of the st...
Autores principales: | Xu, Xin, Ruan, Xiangyan, Zhang, Ying, Cai, Guiju, Ju, Rui, Yang, Yu, Cheng, Jiaojiao, Gu, Muqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569863/ https://www.ncbi.nlm.nih.gov/pubmed/34746100 http://dx.doi.org/10.3389/fbioe.2021.714030 |
Ejemplares similares
-
Identification of PGRMC1 as a Candidate Oncogene for Head and Neck Cancers and Its Involvement in Metabolic Activities
por: Zhao, Yue, et al.
Publicado: (2020) -
Exploring the Application of Bifunctional Metal Chelators in Treating Triple-Negative Breast Cancer
por: Li, Kuo, et al.
Publicado: (2021) -
MicroRNA-181a suppresses norethisterone-promoted tumorigenesis of breast epithelial MCF10A cells through the PGRMC1/EGFR–PI3K/Akt/mTOR signaling pathway
por: Cai, Guiju, et al.
Publicado: (2021) -
Fabrication of Ginsenoside-Based Nanodrugs for Enhanced Antitumor Efficacy on Triple-Negative Breast Cancer
por: Zuo, Shuting, et al.
Publicado: (2022) -
Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer
por: Zeng, Weiwei, et al.
Publicado: (2023)